94 results
8-K
RGBP
Regen BioPharma Inc
15 Mar 19
Regulation FD Disclosure
12:00am
at the Division of Enforcement of the Securities and Exchange Commission indicating that the staff at the Division of Enforcement has commenced an investigation … an investigation into whether the Company timely filed its Form 8-K on March 31, 2017 and whether the Form 8-K was substantively deficient.
On March 13
8-K
RGBP
Regen BioPharma Inc
4 Oct 18
Regulation FD Disclosure
4:30pm
at the Division of Enforcement of the Securities and Exchange Commission indicating that the staff at the Division of Enforcement has commenced an investigation … of the Securities and Exchange Commission indicating that the staff at the Division of Enforcement has commenced an investigation into whether the Company timely
8-K
EX-10.1
RGBP
Regen BioPharma Inc
16 Apr 21
Entry into a Material Definitive Agreement
3:51pm
’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
IN WITNESS WHEREOF … for its attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding
8-K
EX-10.1
4gbixu6ycq kn
29 Apr 24
Entry into a Material Definitive Agreement
4:07pm